Skip to content

Praxis Precision Medicines, Inc. PRAX Business Segments — Other income, net

Similar metrics at other companies

Summit Therapeutics logo
SMMTReportable Segment — Other income, net
$5.79M+47.0%
Veeva Systems logo
VEEVReportable Segment — Other income, net
$74.42M+14.3%
BridgeBio Pharma logo
BBIOReportable Segment — Other income, net
$4.25M-48.3%
PNW
PNWReportable Segment — Other income and (expense), net
-$1M-107%
Primo Brands logo
PRMBReportable Segment — Other income, net
$14.93M
American Homes 4 Rent logo
AMHReportable Segment — Other income and expense, net
$327K-86.6%

Other financials

Income statement

See full
Revenue--100%
Operating income-$105.9M-41.7%
Net income-$92.6M-33.6%
EPS (diluted)-$3.20+2.7%

Balance sheet

See full
Cash & equivalents$536.7M+223%
Total debt$1.4M+31.3%
Total equity$1.4B+221%
Total assets$1.5B+205%

Cash flow

See full
Operating cash flow-$86.2M-62.5%
CapEx$62.0K
Free cash flow-$86.2M-62.6%

Valuation

See full
Market cap$7.87B+1,075%
Enterprise value$7.34B+1,309%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-35.3%-10.9pp
Debt / equity0.0×
Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s business segments — other income, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s business segments — other income, net?
Praxis Precision Medicines, Inc. (PRAX) reported business segments — other income, net of $13.3M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s business segments — other income, net changed year-over-year?
Praxis Precision Medicines, Inc.'s business segments — other income, net increased by 144.8% year-over-year, from $5.43M to $13.3M.